SMS Pharmaceuticals Ltd has informed that on 16th October 2025, it approved a change in security structure related to its 38,50,165 shares in VKT Pharma, which are pledged for Rs.130 crores NCDs, while providing a non-disposal undertaking to Exim Bank for refinancing.